HGTS 7/29/88 
National Institutes of Health staff: 
Paul Aebersold, NCI 
W. French Anderson, NHLBI 
Florence Antoine, NCI 
Leon Baltrucki, NHLBI 
Stanley Barban, NIAID 
R. Michael Blaese, NCI 
Ken Culver, NCI 
David DeGrazia, OD 
Mary Ellen Franko, NCI 
Scott Freeman, NHLBI 
Blair Gatly, NHLBI 
Jay Greenblatt, NCI 
Attam Kasid, NCI 
Becky Lawson, NIAID 
Others: 
James Barrett 
Marie A. Dray, Merck and Co., Inc. 
Martin Eglitis, Genetic Therapy, Inc. 
Carol Ezzell, Nature 
Peter Farnham, American Society for Biochemistry and Molecular Biology 
Julie Gage, Hopkins and Sutter (Attorneys) 
Patricia Hoben, Office of Assistant Secretary for Health, DHHS 
Susan Jenks, Medical World News 
Doug Jolly, Viagene Corporation 
Harold M. Schmeck, Jr., New York Times 
Masami Shimizu, Nihon Keizai Shimbun (Japan Economic Journal) 
Herbert Smith, Food and Drug Administration 
Alan Shipp, Association of American Medical Colleges 
Paul Tolstoshev 
Alan G. Walton, Oxford Partners 
Lisa White, Blue Sheet 
Jim Wilson, Massachusetts Institute of Technology 
Janet Woodcock, Food and Drug Administration 
Robert Lee, NCI 
Rachel Levinson, OD 
Michael Lotze, NCI 
Robert Moen, NHLBI 
Shoshana Morecki, NCI 
Richard Morgan, NHLBI 
James Mule, NCI 
Alan Price, OD 
Uming Shu, NHLBI 
Dinah Singer, NCI 
Gregory Springett, NHLBI 
Diana Striar, NHLBI 
Dave Warren, NCI 
Debbie Wilson, OD 
Recombinant DNA Research, Volume 13 
[181] 
